Liver Damage Suppliers For Served Medical Health Care

NOWDiagnostics Inc., is a leader in innovative diagnostics testing. Dr. Qinwei Shi helped revolutionize lateral flow assay testing using very small sample sizes. Dr. Shi developed and perfected the platform which now is the foundation for all our ...

Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to ...

Darnitsa is the leader of the Ukrainian market in physical terms. 90 years of experience and GMP production certification have allowed us to earn confidence in 16 countries worldwide. We produce 180 products with a focus on cardiology, neurology, ...

HepaRegeniX GmbH is a clinical stage company developing novel therapies for the treatment of acute and chronic liver diseases. Since its start in 2017, HepaRegeniX has successfully discovered and developed several drug candidates for the treatment ...

Diagnostic Automation / Cortez Diagnostics, Inc. is a global leader in diagnostic innovation. Founded in 1989, the company reaches 168 countries with its Broad line of diagnostic test kits. These products include ELISA kits, Rapid Tests, ...

Dynavax is a commercial stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology. Our vision and work ethic ...

Resoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...

Superfluid’s platform technology is applicable to a wide variety of diseases. We are currently focused on Alzheimer’s Disease, where there are urgent medical needs. This minimally invasive approach eliminates the need for spinal taps and ...

In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...